| | Type of cancer | No. of publications (a) | Frequency (a/652) | No. of patients (b) | Frequency (b/61,035) |
| | Digestive system | | | | | | Liver | 148 | 22.70% | 5,627 | 9.21% | | Stomach | 110 | 16.87% | 3,431 | 5.62% | | Intestine | 74 | 11.35% | 2,076 | 3.40% | | Anus/anal rectum | 39 | 5.98% | 1,059 | 1.73% | | Esophagus | 51 | 7.82% | 3,019 | 4.94% | | Pancreas | 28 | 4.29% | 550 | 0.90% | | Gallbladder | 4 | 0.61% | 21 | 0.03% | | Subtotal | 454 | 69.62% | 15,783 | 25.84% | | Respiratory system | | | | | | Lung | 158 | 24.23% | 14,298 | 23.40% | | Subtotal | 158 | 24.23% | 14,298 | 23.40% | | Hematologic/lymphoid system | | | | | | Leukemia | 73 | 11.20% | 3,250 | 5.32% | | Malignant lymphoma | 16 | 2.45% | 480 | 0.79% | | Subtotal | 89 | 13.65% | 3,730 | 6.11% | | Urinary and reproductive systems | | | | | | Cervix | 24 | 3.68% | 1,457 | 2.38% | | Ovary | 17 | 2.61% | 295 | 0.48% | | Bladder | 9 | 1.38% | 222 | 0.36% | | Prostate | 15 | 2.30% | 217 | 0.36% | | Kidney | 5 | 0.77% | 25 | 0.04% | | Penis | 1 | 0.15% | 4 | 0.01% | | Subtotal | 71 | 10.89% | 2,220 | 3.63% | | Endocrine system | | | | | | Breast | 60 | 9.20% | 1,677 | 2.75% | | Thyroid | 12 | 1.84% | 153 | 0.25% | | Head and neck cancer | | | | | | Brain | 10 | 1.53% | 92 | 0.15% | | Parotid gland | 1 | 0.15% | 2 | 0.00% | | Oral cavity | 11 | 1.69% | 83 | 0.14% | | Nasopharynx | 32 | 4.91% | 807 | 1.32% | | Larynx | 5 | 0.77% | 17 | 0.03% | | Subtotal | 59 | 9.05% | 1,001 | 1.64% | | Skeletal and muscular systems | 11 | 1.69% | 178 | 0.29% | | Skin cancer | 11 | 1.69% | 164 | 0.27% | | Multiple myeloma | 7 | 1.07% | 137 | 0.22% | | Malignant mole | 4 | 0.61% | 8 | 0.01% |
| | Total* | 652 | | 61,035 | |
|
|